Latest data from September 24, 2021
Number of Health Center respondents = 6 (75% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 5,412 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 63.38% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 304 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 61.59% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, antigen)2 | Patients Tested Positive, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 23.00% | 19.08% |
| White, Hispanic/Latino Patients | 15.30% | 7.89% |
| Black/African American, Non-Hispanic/Latino Patients | 3.10% | 4.93% |
| Black/African American, Hispanic/Latino Patients | 2.16% | 1.32% |
| Asian Patients3 | 0.67% | 0.66% |
| American Indian/Alaska Native Patients3 | 0.28% | 1.32% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.37% | 0.66% |
| Patients with More than one race3 | 6.25% | 3.95% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 11.70% | 9.87% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 1.87% | 6.91% |
| Unreported/Refused to Report Race and Ethnicity | 35.31% | 43.42% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 556 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 67.71% |
| COVID-19 Immunization Series Completed | 658 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 67.56% |
| COVID-19 Immunization Series Additional | 89 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 29.63% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 27.88% | 29.33% | 64.04% |
| White, Hispanic/Latino Patients | 15.29% | 14.44% | 5.62% |
| Black/African American, Non-Hispanic/Latino Patients | 9.71% | 13.53% | 5.62% |
| Black/African American, Hispanic/Latino Patients | 2.70% | 2.74% | 0.00% |
| Asian Patients3 | 1.08% | 1.98% | 0.00% |
| American Indian/Alaska Native Patients3 | 0.54% | 0.61% | 0.00% |
| Native Hawaiian/Other Pacific Islander Patients3 | 2.16% | 1.52% | 1.12% |
| Patients with More than one race3 | 7.01% | 4.10% | 2.25% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 19.96% | 22.19% | 12.36% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 3.96% | 2.89% | 3.37% |
| Unreported/Refused to Report Race and Ethnicity | 9.71% | 6.69% | 5.62% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 16.67% |
| 1 to 24 Hours | 0.00% |
| More Than 24 Hours | 83.33% |
| N/A | 0.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 0.00% |
| Staffing to administer the vaccine | 33.33% |
| Vaccine confidence | 50.00% |
| Vaccine storage capacity | 16.67% |
| Vaccine supply | 0.00% |
| Other | 0.00% |
| None | 16.67% |
Operations and Staff
| Metrics | Value |
|---|---|
| Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits | 102.50% |
| Average Percent of Health Center Visits Conducted Virtually | 25.00% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 66.67% |
| Number of Mobile Van Sites | 0 |
| Number of Pop-up Clinics | 14 |
| Number of School-Based Vaccination Sites | 7 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 16.67% |
| Refer patients to another organization that provides monoclonal antibody therapies | 16.67% |
| None | 66.67% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 16.67% |
| Patient awareness/education | 0.00% |
| Staffing capacity | 16.67% |
| Therapy administration/onsite logistics | 50.00% |
| Other | 0.00% |
| None | 33.33% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
